Home2CL • FRA
add
BridgeBio Pharma Inc
Previous close
€29.66
Day range
€29.69 - €29.70
Year range
€20.49 - €36.49
Market cap
6.41B USD
Avg Volume
50.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 116.63M | -44.76% |
Operating expense | 217.80M | 5.33% |
Net income | -167.42M | -375.41% |
Net profit margin | -143.55 | -760.61% |
Earnings per share | -0.99 | -691.04% |
EBITDA | -102.52M | -2,020.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 540.60M | 4.02% |
Total assets | 881.64M | 3.80% |
Total liabilities | 2.52B | 33.62% |
Total equity | -1.64B | — |
Shares outstanding | 189.88M | — |
Price to book | -3.42 | — |
Return on assets | -28.82% | — |
Return on capital | -105.37% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -167.42M | -375.41% |
Cash from operations | -199.24M | 9.25% |
Cash from investing | -1.60M | -107.01% |
Cash from financing | 60.33M | -78.42% |
Net change in cash | -140.50M | -269.76% |
Free cash flow | -180.12M | 13.06% |
About
CEO
Founded
2015
Headquarters
Website
Employees
728
